References

Reading list

For the oral-pigmentation case, start with oral-mucosal pigmentation after Melanotan II. The historical melanocortin review supplies the wider lineage, and the kidney-injury case and literature review covers a serious adverse-event signal.

For copper peptides, the 2025 topical GHK review gives the formulation problem considerable space. The excised human skin experiment measures copper penetration, while the hair-count trial concerns a specific combination formulation. For me, a quoted result has to bring its preparation and endpoint along.

For GLOW, the 2026 peptide-therapy review names all three constituents, while the BPC-157 narrative review describes the small human pilot record. Neither reports a trial of the three-peptide mixture. The full source list follows.